BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

959 related articles for article (PubMed ID: 22563571)

  • 1. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management.
    Perry PJ; Wilborn CA
    Ann Clin Psychiatry; 2012 May; 24(2):155-62. PubMed ID: 22563571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
    Sokoro AA; Zivot J; Ariano RE
    Ann Pharmacother; 2011 Sep; 45(9):e50. PubMed ID: 21878660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin syndrome overlapping with neuroleptic malignant syndrome: A case report and approaches for differentially diagnosing the two syndromes.
    Nisijima K
    Asian J Psychiatr; 2015 Dec; 18():100-1. PubMed ID: 26506919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C; Planès S; Logerot S; Villier C; Mallaret M
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome and its controversies.
    Margetić B; Aukst-Margetić B
    Pharmacoepidemiol Drug Saf; 2010 May; 19(5):429-35. PubMed ID: 20306454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malignant neuroleptic syndrome. A review of epidemiology, risk factors, diagnosis, differential diagnosis and pathogenesis of MNS].
    Andreassen MD; Pedersen S
    Ugeskr Laeger; 2000 Mar; 162(10):1366-70. PubMed ID: 10745673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome.
    McHugh TP
    J S C Med Assoc; 1992 Jun; 88(6):303-6. PubMed ID: 1352559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A hazardous side effect of neuroleptics: diagnosis and treatment.
    Epperly TD; McGlaughlin VG; Leo KU
    Geriatrics; 1990 Aug; 45(8):58-62. PubMed ID: 1974232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome and serotonin syndrome in the critical care setting: case analysis.
    Kaufman KR; Levitt MJ; Schiltz JF; Sunderram J
    Ann Clin Psychiatry; 2006; 18(3):201-4. PubMed ID: 16923659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AANA journal course. Update for nurse anesthetists. Neuroleptic malignant syndrome.
    Waldorf S
    AANA J; 2003 Oct; 71(5):389-94. PubMed ID: 14625976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic malignant syndrome from central nervous system insult: 4 cases and a novel treatment strategy. Clinical article.
    Wait SD; Ponce FA; Killory BD; Wallace D; Rekate HL
    J Neurosurg Pediatr; 2009 Sep; 4(3):217-21. PubMed ID: 19772404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome due to olanzapine.
    Hall KL; Taylor WH; Ware MR
    Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative neuroleptic malignant syndrome that occurred repeatedly in a patient with cerebral palsy.
    Tsuchiya N; Morimura E; Hanafusa T; Shinomura T
    Paediatr Anaesth; 2007 Mar; 17(3):281-4. PubMed ID: 17263746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic malignant syndrome secondary to quetiapine.
    Gortney JS; Fagan A; Kissack JC
    Ann Pharmacother; 2009 Apr; 43(4):785-91. PubMed ID: 19299325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosing subtypes of neuroleptic malignant syndrome: an introduction to the Lee-Carroll Scale.
    Carroll BT; Lee JW; Graham KT; Thalassinos A; Thomas C; Kirkhart R
    Ann Clin Psychiatry; 2008; 20(1):47-8. PubMed ID: 18297586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature].
    Marelli A; Bodini P; Dizioli P; Chiodelli G; Guarneri M; Boldori L
    Minerva Med; 1996; 87(1-2):45-51. PubMed ID: 8610025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic Malignant Syndrome.
    Pileggi DJ; Cook AM
    Ann Pharmacother; 2016 Nov; 50(11):973-981. PubMed ID: 27423483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.
    Picard LS; Lindsay S; Strawn JR; Kaneria RM; Patel NC; Keck PE
    Pharmacotherapy; 2008 Apr; 28(4):530-5. PubMed ID: 18363536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuroleptic malignant syndrome. Case reports].
    Berardi D; Troia M; Veronesi L; Ferrari G
    Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.